Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 2Phase NA 1Phase 2/3 1Phase 1 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 437OTHER 196NIH 41NETWORK 31OTHER_GOV 11UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Interventions

aumolertinib 1Radiotherapy, Intensity-Modulated 1Pemetrexed 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Carcinoma, Non-Small-Cell Lung × Clear all
NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation
606 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

ChineseAMS

Phase 3 Completed
394 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡